ZOLL Medical up 13% Pre-Market on Upbeat Earnings

by Eddie Staley, Benzinga Editor
July 29, 2011 9:16 AM | 14 seconds read |
ZOLL Medical ZOLL is up 13% pre-market on the upbeat earnings. The company reported yesterday Q2 EPS $0.42 vs $0.35 Est; Revenues $136.2M vs $129.97M Est. ZOLL Medical is currently trading at $62.29 pre-market, a gain of $6.90 or 12.46%.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Pre-Market OutlookMoversHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!